EN   EN 
 
 
 EUROPEAN  
COMMISSION   
Brussels, XXX   
SANTE/10568/2019 
(POOL/E4/2019/10568/10568 -EN.docx)  
[…](2019) XXX  draft  
 
COMMISSION IMPLEMENTING DECISION  
of XXX  
not approving carbendazim as an existing active substance for use in biocidal products 
of product -type 9  
(Text with EEA relevance)    
EN 1  EN COMMISSION IMPLEMENTING DECISION  
of XXX  
not approving carbendazim as an existing active substance for use in biocidal products 
of product -type 9  
(Text with EEA relevance)  
THE EUROPEAN COMMISSION,  
Having regard to the Treaty on the Functioning of the European Union , 
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the 
Council of 22 May 2012 concerning the making availab le on the market and use of biocidal 
products1, and in particular  the third subparagraph of  Article 89(1) thereof,  
Whereas:  
(1) Commission Delegated Regulation (EU) No 1062/20142 establishes a list of e xisting 
active substances to be evaluated for their possible approval for use in biocidal 
products. That lists includes carbendazim (EC No: 234 -232-0; CAS No 10605 -21-7). 
(2) Carbendazim has been evaluated for use in biocidal products of product -type 9, fibre, 
leather, rubber and polymerised  materials preservatives, as described in Annex V to 
Directive 98/8/EC of the European Parliament and of the Council3, which corresponds 
to product -type 9 as described in Annex V to Regulation (EU) No 528/2012.  
(3) The evaluating competent authority of Germany  submitted the assessment report 
together with its conclusions  to the Commission o n 2 August 2013 . 
(4) In accordance with Article 7(2) of Delegated Regulation (EU) No 1062/2014, the 
opinion of the European Chemicals Agency4 was adopted  on 27 February 2019 by t he 
Biocidal Products Committee, having regard to the conclusions of the evaluating 
competent authority . 
(5) According to that opinion, biocidal products of product -type 9 containing carbendazim  
may not be expected to meet the criteria laid down in Article 19(1 )(b) of Regulation 
(EU) No 528/201 2 as the environmental scenarios evaluated identified unacceptable 
risks to the environment and no safe use could be identified .  
(6) Taking into account the opinion of the European Chemicals Agency, it is not 
appropriate to approve carbendazim for use in biocidal products of product -type 9 , as 
                                                 
1 OJ L 167, 27.6.2012,  p. 1.  
2 Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for 
the systematic examination of all existing active substances contained in biocidal products referred to in 
Regulation (EU) No 528/2012 of the European Pa rliament and of the Co uncil (OJ L 294, 10.10.2014, 
p. 1). 
3 Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the 
placing of biocidal products on the market (OJ L 123, 24.4.1998, p. 1).  
4 Biocidal Products Committee (BPC) opinion on the application for approval of the active substance 
Carbe ndazim, Product type: 9, ECHA/BPC/218/2019, adopted on 27 February 2019 .   
EN 2  EN the conditions laid down in Article 4(1) of Regulation (EU) No 528/2012 are not 
satisfied.   
(7) The measures provided for in this Decision are in accordance with the opin ion of the 
Standing Committee  on Biocidal products,  
HAS ADOPTED THIS DECISION:  
Article 1  
Carbendazim  (EC No: 234 -232-0; CAS No: 10605 -21-7) is not approved as an active 
substance for use in biocidal products of product -type 9 . 
Article 2 
This Decision shal l enter into force on the twentieth day following that of its publication in 
the Official Journal of the European Union . 
Done at Brussels,  
 For the Commission  
The President  
 Jean -Claude JUNCKER